Robert Lisicki - Net Worth and Insider Trading

Robert Lisicki Net Worth

The estimated net worth of Robert Lisicki is at least $2 Million dollars as of 2024-05-09. Robert Lisicki is the EVP, Chief Commercial Officer of Arena Pharmaceuticals Inc and owns about 16,101 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $2 Million. Details can be seen in Robert Lisicki's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Lisicki has not made any transactions after 2021-08-03 and currently still holds the listed stock(s).

Transaction Summary of Robert Lisicki

To

Robert Lisicki Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Lisicki owns 2 companies in total, including Arena Pharmaceuticals Inc (ARNA) , and Cadrenal Therapeutics Inc (CVKD) .

Click here to see the complete history of Robert Lisicki’s form 4 insider trades.

Insider Ownership Summary of Robert Lisicki

Ticker Comapny Transaction Date Type of Owner
ARNA Arena Pharmaceuticals Inc 2021-08-03 EVP & Chief Commercial Officer
CVKD Cadrenal Therapeutics Inc 2023-07-23 director

Robert Lisicki Latest Holdings Summary

Robert Lisicki currently owns a total of 1 stock. Robert Lisicki owns 16,101 shares of Arena Pharmaceuticals Inc (ARNA) as of August 3, 2021, with a value of $2 Million.

Latest Holdings of Robert Lisicki

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARNA Arena Pharmaceuticals Inc 2021-08-03 16,101 99.99 1,609,939

Holding Weightings of Robert Lisicki


Robert Lisicki Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Lisicki has made a total of 5 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 17,500 shares on August 3, 2021, which brought Robert Lisicki around $1 Million.

Insider Trading History of Robert Lisicki

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Lisicki Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Lisicki Ownership Network

Ownership Network List of Robert Lisicki

No Data

Ownership Network Relation of Robert Lisicki


Robert Lisicki Owned Company Details

What does Arena Pharmaceuticals Inc do?

Who are the key executives at Arena Pharmaceuticals Inc?

Robert Lisicki is the EVP & Chief Commercial Officer of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , Executive VP and CBO Vincent Aurentz , and EVP & Head of R&D & and CMO Christopher Cabell .

Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arena Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Lisicki Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Lisicki. You might contact Robert Lisicki via mailing address: C/o Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive, San Diego Ca 92121.

Discussions on Robert Lisicki

No discussions yet.